A Canadian study of the total medical costs for patients with systemic lupus erythematosus and the predictors of costs.
We conducted a cost identification analysis on 164 consecutive patients with systemic lupus erythematosus (SLE) who entered the Montreal General Hospital Lupus Registry between January 1977 and January 1990, compared their costs to the population of Quebec, and determined the predictors of cost.
In January 1990 and 1991, participants completed questionnaires on health services utilization and on employment history over the preceding 6 months, as well as on functional, psychological, and social well-being.
The societal burden of SLE was determined in terms of direct costs (all resources consumed in patient care) and indirect costs (wages lost due to lack of work force participation because of morbidity).
Mots-clés Pascal : Lupus érythémateux, Disséminé, Homme, Economie santé, Analyse coût, Etude statistique, Canada, Epidémiologie, Amérique du Nord, Amérique, Peau pathologie, Tissu conjonctif pathologie, Maladie système, Maladie autoimmune, Immunopathologie
Mots-clés Pascal anglais : Lupus erythematosus, Disseminated, Human, Health economy, Cost analysis, Statistical study, Canada, Epidemiology, North America, America, Skin disease, Connective tissue disease, Systemic disease, Autoimmune disease, Immunopathology
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 94-0065341
Code Inist : 002B30A01A2. Création : 199406.